• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于增强药物递送和癌症治疗的可变形纳米载体。

Deformable nanocarriers for enhanced drug delivery and cancer therapy.

作者信息

Cao Ziyang, Liu Jing, Yang Xianzhu

机构信息

Department of General Surgery Guangzhou First People's Hospital the Second Affiliated Hospital South China University of Technology Guangzhou People's Republic of China.

Center for Medical Research on Innovation and Translation Institute of Clinical Medicine School of Medicine Guangzhou First People's Hospital South China University of Technology Guangzhou People's Republic of China.

出版信息

Exploration (Beijing). 2024 Mar 15;4(5):20230037. doi: 10.1002/EXP.20230037. eCollection 2024 Oct.

DOI:10.1002/EXP.20230037
PMID:39439489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11491306/
Abstract

Recently, the field of nanomedicine has witnessed substantial advancements in the development of nanocarriers for targeted drug delivery, emerges as promising platforms to enhance therapeutic efficacy and minimize adverse effects associated with conventional chemotherapy. Notably, deformable nanocarriers have garnered considerable attention due to their unique capabilities of size changeable, tumor-specific aggregation, stimuli-triggered disintegration, and morphological transformations. These deformable nanocarriers present significant opportunities for revolutionizing drug delivery strategies, by responding to specific stimuli or environmental cues, enabling achieved various functions at the tumor site, including size-shrinkage nanocarriers enhance drug penetration, aggregative nanocarriers enhance retention effect, disintegrating nanocarriers enable controlled drug release, and shape-changing nanocarriers improve cellular uptake, allowing for personalized treatment approaches and combination therapies. This review provides an overview of recent developments and applications of deformable nanocarriers for enhancing tumor therapy, underscores the diverse design strategies employed to create deformable nanocarriers and elucidates their remarkable potential in targeted tumor therapy.

摘要

近年来,纳米医学领域在用于靶向给药的纳米载体开发方面取得了重大进展,成为增强治疗效果和最大限度减少传统化疗相关副作用的有前景的平台。值得注意的是,可变形纳米载体因其尺寸可变、肿瘤特异性聚集、刺激触发崩解和形态转变等独特能力而备受关注。这些可变形纳米载体通过响应特定刺激或环境线索,在肿瘤部位实现各种功能,包括尺寸缩小的纳米载体增强药物渗透、聚集性纳米载体增强滞留效应、崩解性纳米载体实现可控药物释放以及形状改变的纳米载体改善细胞摄取,从而为彻底改变给药策略提供了重大机遇,实现个性化治疗方法和联合疗法。本综述概述了可变形纳米载体在增强肿瘤治疗方面的最新进展和应用,强调了用于创建可变形纳米载体的多种设计策略,并阐明了它们在靶向肿瘤治疗中的巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/25f5235a2acf/EXP2-4-20230037-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/de7abcc9dc71/EXP2-4-20230037-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/b33961a945c1/EXP2-4-20230037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/751e1798a150/EXP2-4-20230037-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/619d20a026dc/EXP2-4-20230037-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/e5aff0eaa118/EXP2-4-20230037-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/dfe5e4cb6bc6/EXP2-4-20230037-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/ebc3c110ea80/EXP2-4-20230037-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/2b51b2aa6885/EXP2-4-20230037-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/57489dc7b742/EXP2-4-20230037-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/00cb0b1c7db6/EXP2-4-20230037-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/25f5235a2acf/EXP2-4-20230037-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/de7abcc9dc71/EXP2-4-20230037-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/b33961a945c1/EXP2-4-20230037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/751e1798a150/EXP2-4-20230037-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/619d20a026dc/EXP2-4-20230037-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/e5aff0eaa118/EXP2-4-20230037-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/dfe5e4cb6bc6/EXP2-4-20230037-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/ebc3c110ea80/EXP2-4-20230037-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/2b51b2aa6885/EXP2-4-20230037-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/57489dc7b742/EXP2-4-20230037-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/00cb0b1c7db6/EXP2-4-20230037-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e984/11491306/25f5235a2acf/EXP2-4-20230037-g006.jpg

相似文献

1
Deformable nanocarriers for enhanced drug delivery and cancer therapy.用于增强药物递送和癌症治疗的可变形纳米载体。
Exploration (Beijing). 2024 Mar 15;4(5):20230037. doi: 10.1002/EXP.20230037. eCollection 2024 Oct.
2
Advancements in pH-responsive nanocarriers: enhancing drug delivery for tumor therapy.pH响应性纳米载体的进展:增强用于肿瘤治疗的药物递送
Expert Opin Drug Deliv. 2023 Jul-Dec;20(11):1623-1642. doi: 10.1080/17425247.2023.2292678. Epub 2023 Dec 20.
3
Polymeric nanocarriers as stimuli-responsive systems for targeted tumor (cancer) therapy: Recent advances in drug delivery.用于靶向肿瘤(癌症)治疗的聚合物纳米载体作为刺激响应系统:药物递送的最新进展
Saudi Pharm J. 2020 Mar;28(3):255-265. doi: 10.1016/j.jsps.2020.01.004. Epub 2020 Jan 24.
4
Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.多功能和刺激响应型纳米载体用于靶向治疗递送。
Expert Opin Drug Deliv. 2021 Feb;18(2):205-227. doi: 10.1080/17425247.2021.1828339. Epub 2020 Oct 8.
5
Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.内在刺激响应型纳米载体用于抗菌药物的智能药物递送:过去二十年的深入综述。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Jan;13(1):e1664. doi: 10.1002/wnan.1664. Epub 2020 Aug 17.
6
Stimuli-responsive nanocarriers for therapeutic applications in cancer.用于癌症治疗应用的刺激响应性纳米载体。
Cancer Biol Med. 2021 Mar 25;18(2):319-35. doi: 10.20892/j.issn.2095-3941.2020.0496.
7
Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.光响应性和双靶向脂质体:从机制到靶向策略。
Molecules. 2024 Jan 30;29(3):636. doi: 10.3390/molecules29030636.
8
Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review.用于抗癌药物递送的氧化还原操纵纳米载体:系统评价。
J Nanobiotechnology. 2024 Sep 28;22(1):587. doi: 10.1186/s12951-024-02859-w.
9
Unveiling innovative therapeutic strategies and future trajectories on stimuli-responsive drug delivery systems for targeted treatment of breast carcinoma.揭示用于乳腺癌靶向治疗的刺激响应性药物递送系统的创新治疗策略和未来发展轨迹。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):3747-3770. doi: 10.1007/s00210-023-02885-9. Epub 2023 Dec 14.
10
Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms.刺激响应型影像引导纳米载体作为智能药物传递平台。
Expert Opin Drug Deliv. 2022 Nov;19(11):1487-1504. doi: 10.1080/17425247.2022.2134853. Epub 2022 Oct 18.

引用本文的文献

1
Exploring the Neuroprotective Role of Selenium: Implications and Perspectives for Central Nervous System Disorders.探索硒的神经保护作用:对中枢神经系统疾病的影响及展望
Exploration (Beijing). 2025 Apr 1;5(4):e20240415. doi: 10.1002/EXP.20240415. eCollection 2025 Aug.
2
Thylakoids for enhanced photodynamic therapy in hypoxic tumours.用于增强缺氧肿瘤光动力治疗的类囊体。
Sci Technol Adv Mater. 2025 Jul 25;26(1):2537000. doi: 10.1080/14686996.2025.2537000. eCollection 2025.
3
Tertiary Amine Oxide-Containing Zwitterionic Polymers: From Material Design to Biomedical Applications.

本文引用的文献

1
Promoting the Recruitment, Engagement, and Reinvigoration of Effector T Cells via an Injectable Hydrogel with a Supramolecular Binding Capability for Cancer Immunotherapy.通过一种具有超分子结合能力的可注射水凝胶促进效应 T 细胞的募集、参与和恢复活力用于癌症免疫治疗。
Adv Mater. 2023 Nov;35(47):e2309667. doi: 10.1002/adma.202309667. Epub 2023 Oct 18.
2
A Polymeric Nanosponge as a Broad-Spectrum Reactive Oxygen Species Scavenger for Acute Kidney Injury Treatment.一种用于治疗急性肾损伤的广谱活性氧清除剂——聚合物纳米海绵
Nano Lett. 2023 Oct 11;23(19):8978-8987. doi: 10.1021/acs.nanolett.3c02531. Epub 2023 Sep 19.
3
含叔胺氧化物的两性离子聚合物:从材料设计到生物医学应用
Pharmaceutics. 2025 Jun 27;17(7):846. doi: 10.3390/pharmaceutics17070846.
4
Dual asparagine-depriving nanoparticles against solid tumors.用于对抗实体瘤的双天冬酰胺剥夺纳米颗粒。
Nat Commun. 2025 Jul 1;16(1):5675. doi: 10.1038/s41467-025-60798-y.
5
Cancer Immunotherapy Based on the Bidirectional Reprogramming of the Tumor Microenvironment by a "Brakes Off/ Step on the Accelerator" Core-Shell Manganese Phosphate/siPD-L1 Modulator.基于“松开刹车/踩下油门”核壳型磷酸锰/硅基程序性死亡受体1配体调节剂对肿瘤微环境进行双向重编程的癌症免疫疗法
Exploration (Beijing). 2025 Feb 9;5(3):270009. doi: 10.1002/EXP.70009. eCollection 2025 Jun.
6
Advanced Pharmaceutical Nanotechnologies Applied for Chinese Herbal Medicines.应用于中草药的先进药物纳米技术
Adv Sci (Weinh). 2025 Aug;12(31):e00167. doi: 10.1002/advs.202500167. Epub 2025 Jun 20.
7
Endosomal disruption by co-encapsulating gentamicin in lipid nanoparticles for efficient siRNA delivery and cancer therapy.通过将庆大霉素共包封在脂质纳米颗粒中实现内体破坏,以实现高效的siRNA递送和癌症治疗。
Asian J Pharm Sci. 2025 Jun;20(3):101011. doi: 10.1016/j.ajps.2024.101011. Epub 2024 Dec 16.
8
Layered double hydroxides for regenerative nanomedicine and tissue engineering: recent advances and future perspectives.用于再生纳米医学和组织工程的层状双氢氧化物:最新进展与未来展望。
J Nanobiotechnology. 2025 May 22;23(1):370. doi: 10.1186/s12951-025-03448-1.
9
Extracellular vesicle-mediated gene therapy targets BRAF-mutant colorectal cancer by inhibiting the MEK1/2-ERK1/2 pathway.细胞外囊泡介导的基因疗法通过抑制MEK1/2-ERK1/2途径靶向BRAF突变型结直肠癌。
J Nanobiotechnology. 2025 Feb 20;23(1):129. doi: 10.1186/s12951-025-03205-4.
10
Preparation of Diosgenin-Functionalized Gold Nanoparticles: From Synthesis to Antitumor Activities.薯蓣皂苷元功能化金纳米粒子的制备:从合成到抗肿瘤活性
Int J Mol Sci. 2025 Jan 27;26(3):1088. doi: 10.3390/ijms26031088.
Therapeutic Copolymer from Salicylic Acid and l-Phenylalanine as a Nanosized Drug Carrier for Orthotopic Breast Cancer with Lung Metastasis.
水杨酸和 l-苯丙氨酸的治疗性共聚物作为一种纳米药物载体用于原位乳腺癌伴肺转移
ACS Appl Mater Interfaces. 2023 Sep 6;15(35):41743-41754. doi: 10.1021/acsami.3c08608. Epub 2023 Aug 23.
4
Light responsive nucleic acid for biomedical application.用于生物医学应用的光响应性核酸。
Exploration (Beijing). 2022 Apr 6;2(5):20210099. doi: 10.1002/EXP.20210099. eCollection 2022 Oct.
5
Harnessing anti-tumor and tumor-tropism functions of macrophages via nanotechnology for tumor immunotherapy.通过纳米技术利用巨噬细胞的抗肿瘤和肿瘤趋向性功能进行肿瘤免疫治疗。
Exploration (Beijing). 2022 Feb 25;2(3):20210166. doi: 10.1002/EXP.20210166. eCollection 2022 Jun.
6
A bispecific glycopeptide spatiotemporally regulates tumor microenvironment for inhibiting bladder cancer recurrence.双特异性糖肽时空调节肿瘤微环境抑制膀胱癌复发。
Sci Adv. 2023 Mar;9(9):eabq8225. doi: 10.1126/sciadv.abq8225. Epub 2023 Mar 1.
7
A Magnetically Driven Amoeba-Like Nanorobot for Whole-Process Active Drug Transport.磁驱动的变形虫样纳米机器人用于全过程主动药物输送。
Adv Sci (Weinh). 2023 Mar;10(7):e2204793. doi: 10.1002/advs.202204793. Epub 2023 Jan 25.
8
Size-tunable lipid vectors for controlled local delivery of siRNA from gene activated matrix.用于从基因激活基质中控制局部递送 siRNA 的尺寸可调脂质载体。
Acta Biomater. 2022 Nov;153:97-107. doi: 10.1016/j.actbio.2022.09.016. Epub 2022 Sep 13.
9
Photoactivatable Silencing Extracellular Vesicle (PASEV) Sensitizes Cancer Immunotherapy.光激活沉默细胞外囊泡(PASEV)增强癌症免疫治疗。
Adv Mater. 2022 Sep;34(35):e2204765. doi: 10.1002/adma.202204765. Epub 2022 Aug 2.
10
Bioengineered nanogels for cancer immunotherapy.用于癌症免疫治疗的生物工程纳米凝胶。
Chem Soc Rev. 2022 Jun 20;51(12):5136-5174. doi: 10.1039/d2cs00247g.